Related Experiment Video
Updated: Dec 24, 2025
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.0K
Whole leukemia cell vaccines: Past progress and future directions
Young Sok Ji1, Seong Kyu Park2, Seongho Ryu3
1Department of Pathology, School of Medicine, Soonchunhyang University, 25 Bongjeong-ro, Dongnam-gu, Cheonan-si, Chungcheongnam-do 31151, Republic of Korea.
Vaccine
|April 14, 2020
Summary
Whole leukemia cell vaccines offer a promising immunotherapy to combat leukemia relapse by stimulating immune responses. Enhancing their immunogenicity is key to improving therapeutic efficacy against leukemia.
Area of Science:
- Immunology
- Oncology
- Cellular Therapy
Background:
- Allogeneic hematopoietic stem cell transplantation induces graft-versus-leukemia but carries risks of graft-versus-host disease.
- Active immunotherapy, specifically leukemia vaccines, aims to generate leukemia-specific immune responses without adverse alloimmune reactions.
Purpose of the Study:
- To review the progress of whole leukemia cell vaccines.
- To focus on strategies for enhancing their immunogenicity.
- To discuss future directions and emerging concepts in leukemia vaccine development.
Main Methods:
- Review of existing literature on whole leukemia cell vaccines.
- Analysis of strategies to improve vaccine immunogenicity.
- Exploration of novel concepts like immunogenic cell death and necroptosis.
Main Results:
- Whole leukemia cell vaccines can induce immune responses against multiple unknown antigens.
- Strategies to enhance immunogenicity are crucial for therapeutic efficacy.
- Emerging concepts offer new avenues for vaccine development.
Conclusions:
- Whole leukemia cell vaccines represent a viable immunotherapy for leukemia.
- Further research into enhancing immunogenicity and exploring novel mechanisms is warranted.
- These vaccines hold potential for reducing leukemia relapse without the risks associated with allogeneic transplantation.
Related Concept Videos
01:30Cancer Vaccines
872
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
872
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:29Microorganisms in Medicine and Therapeutics
845
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
845
01:22Bone Marrow Sampling and Transplants
734
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
734